Patient Data and BRIDgE

An exterior shot of The Royal Marsden hospital in Chelsea

What data is used in BRIDgE?

Researchers can be provided with data from the Trust’s data warehouse, containing data collected during routine clinical care, as well as data from clinical trials where patient consent has been given to allow its use in future research. BRIDgE workspaces also allow researchers to upload data from other sources. All data in BRIDgE is de-identified to protect patient confidentiality.

Who has access to BRIDgE Data?

Data in BRIDgE is only made available to individuals (for example academics and innovators) for cancer research purposes. Access is carefully authorised, monitored and audited by The Royal Marsden Committee for Clinical Research and Information Governance Committee, BRIDgE team and patient representatives.

Anyone accessing the data must sign the BRIDgE Terms and Conditions to ensure that researchers adhere to Trust policies on data governance. For further details please read the The Royal Marsden's privacy policy.

How is patient data making a difference?

Data collected within the health and care system is hugely valuable to provide direct patient care, to help the planning of services in a local area, for research and for the development of innovations.

The projects enabled by BRIDgE will provide information and tools that:

  • help to discover factors that cause cancer
  • support the early diagnosis of cancer
  • help hospital staff to make decisions about patient care and services
  • help to identify new treatments for cancer
  • help to enable the use of methods such as Artificial Intelligence and machine learning
  • help to test AI applications created by commercial companies so that they can be used to improve patient care and NHS efficiency

If you have any questions about BRIDgE and how your data may be used, contact [email protected]